Inventiva (IVA) Non-Current Debt (2018 - 2025)
Inventiva's (IVA) quarterly Non-Current Debt came in at $58.4 billion in Q2 2025, up 115678.89% year-on-year from N/an in Q2 2024, and up 12.79% quarter-over-quarter from $51.8 billion in Q4 2024.
Inventiva (IVA) Non-Current Debt (2018 - 2025) Analysis & Trends
Inventiva's Non-Current Debt history runs 8 years deep, the most recent figure standing at $58.4 billion for Q2 2025.
- On a quarterly basis, Non-Current Debt rose 115678.89% year-over-year to $58.4 billion in Q2 2025; TTM through Jun 2025 was $58.4 billion, a 115678.89% increase from a year earlier, with the FY2024 full-year figure at $51.8 billion, up 88893.02% from the prior year.
- Non-Current Debt climbed to $58.4 billion in Q2 2025 per IVA's latest filing, from $51.8 billion in the prior quarter.
- Across five years, Non-Current Debt topped out at $58.4 billion in Q2 2025 and bottomed at $10.1 million in Q4 2021.
- The 5-year median for Non-Current Debt is $47.9 million (2022), against an average of $12.5 billion.
- Across the five-year window, Non-Current Debt soared 118026.67% in 2022 and slumped 99.76% in 2023, its largest moves.
- Year by year, Non-Current Debt stood at $10.1 million in 2021, then surged by 347.99% to $45.3 million in 2022, then advanced by 28.48% to $58.2 million in 2023, then jumped by 88893.02% to $51.8 billion in 2024, then climbed by 12.79% to $58.4 billion in 2025.
- Per Business Quant, the three latest IVA Non-Current Debt figures stand at $58.4 billion (Q2 2025), $51.8 billion (Q4 2024), and $50.4 million (Q2 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 105.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 842.92 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Inventiva | 842.48 Mn | 842.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 58.41 Bn |
| Dec 31, 2024 | 51.78 Bn |
| Jun 30, 2024 | 50.45 Mn |
| Dec 31, 2023 | 58.19 Mn |
| Jun 30, 2023 | 33.77 Mn |
| Dec 31, 2022 | 45.29 Mn |
| Jun 30, 2022 | 14.34 Bn |
| Dec 31, 2021 | 10.11 Mn |
| Jun 30, 2021 | 12.14 Mn |
| Mar 31, 2021 | 12.15 Mn |
| Dec 31, 2020 | 11.97 Mn |
| Dec 31, 2019 | 2,213.78 |
| Dec 31, 2018 | 84,463.34 |